 |


|
 |

Kim M. Schmid
Minneapolis, Minnesota
Kim Schmid focuses her litigation practice defending companies in drug and medical device cases in courts across the country. In addition to her defense litigation practice where she is currently serving as National Coordinating Counsel in medical device mass tort litigation, she advises her clients on FDA regulatory compliance and reporting requirements.
In courts, Kim has successfully tried cases and defended medical device products including latex gloves, breast implants, hip stem implants, infusion pumps, orthopedic devices, implantable cardiac care devices, suction devices, surgical instruments, device monitors and blood warming units to name a few. She has defended IDE products utilized in clinical trials as well as Class I, II and III FDA cleared devices. Kim has defended pharmaceutical cases involving generics, branded, OTC and Rx medications. She has written articles and presented at national seminars on issues specific to drug and device litigation such as preemption, successful Daubert challenges and other evidence based motions. Kim has defended individual lawsuits, class actions, cases involved in mass tort and multi-district litigation (MDL).
Kim is Managing Partner of our Minneapolis office and is also an active member of the DRI and ABA's Drug and Medical Device Subcommittees and LifeScience Alley.
- Drug and Medical Device Litigation
- Automotive
- Minnesota, 1988
- Wisconsin, 1997
- U.S. District Court District of Minnesota, 1988
- U.S. District Court Eastern District of Wisconsin, 2004
- U.S. District Court Western District of Wisconsin, 2004
- U.S. Court of Appeals 6th Circuit, 2006
- William Mitchell College of Law, St Paul, Minnesota,
1988
J.D. Honors: Cum Laude
Law Review:
Associate Editor, William Mitchell Law Review, 1987 - 1988
- St. Cloud State University, St. Cloud, Minnesota,
1982
B.A. Honors: Cum Laude
- College of Saint Benedict, Saint Joseph, Minnesota
- Combating Abusive Pleading With Iqbal/Twombly (co-authored with William N.G. Barron IV), Law360.com, December 8, Guest Column, 2009
- The Iqbal/Twombly Decisions (co-authored with William N.G. Barron IV), Medical Malpractice Law & Strategy, Law Journal Newsletters, December, 2009
- Wyeth v Levine: Forecasting the Future of Preemption in Pharmaceutical Cases, Andrews Medical Devices Litigation Reporter, 15 No. 24 ANMDLR 10, 2009
- Federal Jurisdiction Based on Removal: A 50-State Survey, ABA Practice Essentials Book (Chapter on Minnesota), 2008
- "Riegel v. Medtronic: Better Off Without It?" (co-authored with Shane Bohnen), Product Liability Law 360, August 1, 2008
- Fast Food in the Gunsights - - Class Actions as Political Weapons, The Bureau of National Affairs, Inc., Washington, D.C., 2002
- Minnesota Rejects Alternative Design Test in Products Liability Law 14 William Mitchell Law Review 198, 1987
- Dual Capacity Exception Unlikely in Minnesota 14 William Mitchell Law Review 204, 1987
- Eli Lilly and Company
- Breg, Inc.
- Medmarc Insurance Company
- Cynacon/Ocusoft
- C.B. Fleet Company, Inc.
- Chubb Group of Insurance Companies
- Thoratec Corporation
- Mitsubishi Motor Sales of America
- Nissan Motor Co.
- 21st Annual Medical Device Seminar - "Reigel v. Metronic Decision and Preemption", Sanders Conkright & Warren LLP and Medmarc,
June 11, 2008
-
June 13, 2008
- MNASQ Biomedical Focus Group - "Hot Topics in Medical Device Litigation", February,
2007
- Defense Research Institute, Inc.
- Drug and Medical Device Subcommittee
- LifeScience Alley
- Minnesota State Bar Association
- State Bar of Wisconsin
- 1959, St. Cloud, Minnesota
|
 |
|